世界のメチシリン耐性黄色ブドウ球菌（MRSA）薬市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-2104Z09218 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、メチシリン耐性黄色ブドウ球菌（MRSA）薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。メチシリン耐性黄色ブドウ球菌（MRSA）薬の種類別市場規模（オキサゾリジノン、リポペプチド、セファロスポリン、テトラサイクリン、葉酸拮抗薬、リポ糖ペプチド、その他）、用途別市場規模（経口、非経口）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・メチシリン耐性黄色ブドウ球菌（MRSA）薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Medicines Company、Basilea Pharmaceutica、Theravance Biopharma、Allergan、3M、Pfizer、Merck ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：オキサゾリジノン、リポペプチド、セファロスポリン、テトラサイクリン、葉酸拮抗薬、リポ糖ペプチド、その他 ・用途別分析2016年-2026年：経口、非経口 ・メチシリン耐性黄色ブドウ球菌（MRSA）薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・メチシリン耐性黄色ブドウ球菌（MRSA）薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・メチシリン耐性黄色ブドウ球菌（MRSA）薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・メチシリン耐性黄色ブドウ球菌（MRSA）薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・メチシリン耐性黄色ブドウ球菌（MRSA）薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Oxazolidinone
Lipopeptide
Cephalosporin
Tetracycline
Folate Antagonists
Lipoglycopeptide
Others

Market segment by Application can be divided into
Oral
Parenteral

The key market players for global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market are listed below:
Medicines Company
Basilea Pharmaceutica
Theravance Biopharma
Allergan
3M
Pfizer
Merck

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Oxazolidinone
1.2.3 Lipopeptide
1.2.4 Cephalosporin
1.2.5 Tetracycline
1.2.6 Folate Antagonists
1.2.7 Lipoglycopeptide
1.2.8 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Oral
1.3.3 Parenteral
1.4 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size & Forecast
1.4.1 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales in Value (2016-2026))
1.4.2 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales in Volume (2016-2026)
1.4.3 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Price by Type (2016-2026) & (USD/MT)
1.5 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Production Capacity Analysis
1.5.1 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Total Production Capacity (2016-2026)
1.5.2 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Drivers
1.6.2 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Restraints
1.6.3 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Medicines Company
2.1.1 Medicines Company Details
2.1.2 Medicines Company Major Business
2.1.3 Medicines Company Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Product and Services
2.1.4 Medicines Company Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Basilea Pharmaceutica
2.2.1 Basilea Pharmaceutica Details
2.2.2 Basilea Pharmaceutica Major Business
2.2.3 Basilea Pharmaceutica Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Product and Services
2.2.4 Basilea Pharmaceutica Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Theravance Biopharma
2.3.1 Theravance Biopharma Details
2.3.2 Theravance Biopharma Major Business
2.3.3 Theravance Biopharma Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Product and Services
2.3.4 Theravance Biopharma Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Allergan
2.4.1 Allergan Details
2.4.2 Allergan Major Business
2.4.3 Allergan Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Product and Services
2.4.4 Allergan Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 3M
2.5.1 3M Details
2.5.2 3M Major Business
2.5.3 3M Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Product and Services
2.5.4 3M Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Product and Services
2.6.4 Pfizer Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Product and Services
2.7.4 Merck Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Manufacturer
3.1 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Manufacturer Market Share
3.4.2 Top 6 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Manufacturer Market Share
3.5 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size by Region
4.1.1 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Region (2016-2026)
4.2 North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue (2016-2026)
4.3 Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue (2016-2026)
4.4 Asia-Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue (2016-2026)
4.5 South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue (2016-2026)
4.6 Middle East and Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales in Volume by Type (2016-2026)
5.2 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Type (2016-2026)
5.3 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales in Volume by Application (2016-2026)
6.2 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Application (2016-2026)
6.3 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Type (2016-2026)
7.2 North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Application (2016-2026)
7.3 North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size by Country
7.3.1 North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Type (2016-2026)
8.2 Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Application (2016-2026)
8.3 Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size by Country
8.3.1 Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size by Region
9.3.1 Asia-Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Type (2016-2026)
10.2 South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Application (2016-2026)
10.3 South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size by Country
10.3.1 South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size by Country
11.3.1 Middle East & Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Typical Distributors
12.3 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Medicines Company Basic Information, Manufacturing Base and Competitors
Table 4. Medicines Company Major Business
Table 5. Medicines Company Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Product and Services
Table 6. Medicines Company Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Basilea Pharmaceutica Basic Information, Manufacturing Base and Competitors
Table 8. Basilea Pharmaceutica Major Business
Table 9. Basilea Pharmaceutica Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Product and Services
Table 10. Basilea Pharmaceutica Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Theravance Biopharma Basic Information, Manufacturing Base and Competitors
Table 12. Theravance Biopharma Major Business
Table 13. Theravance Biopharma Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Product and Services
Table 14. Theravance Biopharma Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Allergan Basic Information, Manufacturing Base and Competitors
Table 16. Allergan Major Business
Table 17. Allergan Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Product and Services
Table 18. Allergan Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. 3M Basic Information, Manufacturing Base and Competitors
Table 20. 3M Major Business
Table 21. 3M Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Product and Services
Table 22. 3M Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Pfizer Basic Information, Manufacturing Base and Competitors
Table 24. Pfizer Major Business
Table 25. Pfizer Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Product and Services
Table 26. Pfizer Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Merck Basic Information, Manufacturing Base and Competitors
Table 28. Merck Major Business
Table 29. Merck Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Product and Services
Table 30. Merck Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Manufacturer (2019-2021e) & (MT)
Table 32. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 33. Market Position of Manufacturers in Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 34. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Production Capacity by Company, (MT): 2020 VS 2021
Table 35. Head Office and Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Production Site of Key Manufacturer
Table 36. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Region (2016-2021e) & (MT)
Table 37. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Region (2021-2026) & (MT)
Table 38. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 39. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Region (2021-2026) & (USD Million)
Table 40. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Type (2016-2021e) & (MT)
Table 41. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Type (2021-2026) & (MT)
Table 42. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 43. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Type (2021-2026) & (USD Million)
Table 44. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Price by Type (2016-2021e) & (USD/MT)
Table 45. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Price by Type (2021-2026) & (USD/MT)
Table 46. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Application (2016-2021e) & (MT)
Table 47. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Application (2021-2026) & (MT)
Table 48. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 49. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Application (2021-2026) & (USD Million)
Table 50. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Price by Application (2016-2021e) & (USD/MT)
Table 51. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Price by Application (2021-2026) & (USD/MT)
Table 52. North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Country (2016-2021e) & (MT)
Table 53. North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Country (2021-2026) & (MT)
Table 54. North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 55. North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Country (2021-2026) & (USD Million)
Table 56. North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Type (2016-2021e) & (MT)
Table 57. North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Type (2021-2026) & (MT)
Table 58. North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Application (2016-2021e) & (MT)
Table 59. North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Application (2021-2026) & (MT)
Table 60. Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Country (2016-2021e) & (MT)
Table 61. Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Country (2021-2026) & (MT)
Table 62. Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 63. Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Country (2021-2026) & (USD Million)
Table 64. Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Type (2016-2021e) & (MT)
Table 65. Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Type (2021-2026) & (MT)
Table 66. Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Application (2016-2021e) & (MT)
Table 67. Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Application (2021-2026) & (MT)
Table 68. Asia-Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Region (2016-2021e) & (MT)
Table 69. Asia-Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Region (2021-2026) & (MT)
Table 70. Asia-Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 71. Asia-Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Region (2021-2026) & (USD Million)
Table 72. Asia-Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Type (2016-2021e) & (MT)
Table 73. Asia-Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Type (2021-2026) & (MT)
Table 74. Asia-Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Application (2016-2021e) & (MT)
Table 75. Asia-Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Application (2021-2026) & (MT)
Table 76. South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Country (2016-2021e) & (MT)
Table 77. South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Country (2021-2026) & (MT)
Table 78. South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 79. South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Country (2021-2026) & (USD Million)
Table 80. South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Type (2016-2021e) & (MT)
Table 81. South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Type (2021-2026) & (MT)
Table 82. South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Application (2016-2021e) & (MT)
Table 83. South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Application (2021-2026) & (MT)
Table 84. Middle East & Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Country (2016-2021e) & (MT)
Table 85. Middle East & Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Country (2021-2026) & (MT)
Table 86. Middle East & Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 87. Middle East & Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Country (2021-2026) & (USD Million)
Table 88. Middle East & Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Type (2016-2021e) & (MT)
Table 89. Middle East & Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Type (2021-2026) & (MT)
Table 90. Middle East & Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Application (2016-2021e) & (MT)
Table 91. Middle East & Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Application (2021-2026) & (MT)
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Typical Distributors
Table 95. Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Typical Customers
List of Figures
Figure 1. Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Picture
Figure 2. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Type in 2020
Figure 3. Oxazolidinone
Figure 4. Lipopeptide
Figure 5. Cephalosporin
Figure 6. Tetracycline
Figure 7. Folate Antagonists
Figure 8. Lipoglycopeptide
Figure 9. Others
Figure 10. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Application in 2020
Figure 11. Oral
Figure 12. Parenteral
Figure 13. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size, (USD Million) & (MT): 2020 VS 2021 VS 2026
Figure 14. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 15. United States Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Canada Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Mexico Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Germany Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. France Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. United Kingdom Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Russia Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Italy Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. China Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Japan Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Korea Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. India Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Southeast Asia Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Australia Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Brazil Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Egypt Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Saudi Arabia Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. South Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Turkey Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales (2016-2026) & (MT)
Figure 35. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Production Capacity (2016-2026) & (MT)
Figure 36. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 37. Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Drivers
Figure 38. Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Restraints
Figure 39. Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Trends
Figure 40. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Manufacturer in 2020
Figure 41. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Manufacturer in 2020
Figure 42. Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 43. Top 3 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Manufacturer (Revenue) Market Share in 2020
Figure 44. Top 6 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Manufacturer (Revenue) Market Share in 2020
Figure 45. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Region (2016-2026)
Figure 46. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Region (2016-2026)
Figure 47. North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue (2016-2026) & (USD Million)
Figure 48. Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue (2016-2026) & (USD Million)
Figure 49. Asia-Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue (2016-2026) & (USD Million)
Figure 50. South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue (2016-2026) & (USD Million)
Figure 51. Middle East & Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue (2016-2026) & (USD Million)
Figure 52. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Type (2016-2026)
Figure 53. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Type (2016-2026)
Figure 54. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Price by Type (2016-2026) & (USD/MT)
Figure 55. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Application (2016-2026)
Figure 56. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Application (2016-2026)
Figure 57. Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Price by Application (2016-2026) & (USD/MT)
Figure 58. North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Country (2016-2026)
Figure 59. North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Country (2016-2026)
Figure 60. North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Type (2016-2026)
Figure 61. North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Application (2016-2026)
Figure 62. Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Country (2016-2026)
Figure 63. Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Country (2016-2026)
Figure 64. Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Type (2016-2026)
Figure 65. Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Application (2016-2026)
Figure 66. Asia-Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Application (2016-2026)
Figure 70. South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Country (2016-2026)
Figure 71. South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Country (2016-2026)
Figure 72. South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Type (2016-2026)
Figure 73. South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Application (2016-2026)
Figure 74. Middle East & Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Type (2016-2026)
Figure 77. Middle East & Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Application (2016-2026)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source

---